Publications by authors named "Ryan B Edwards"

Claim this Profile
B
Bubble in, bubble out: Lessons for the COVID-19 recovery and future crises from the Pacific.
Ryan B Edwards

World Dev· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decentralization and the environment: Assessing smallholder oil palm development in Indonesia.
Rosamond L Naylor, Matthew M Higgins, Ryan B Edwards, Walter P Falcon

Ambio· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard pentostatin dose reductions in renal insufficiency are not adequate: selected patients with steroid-refractory acute graft-versus-host disease.
Ming J Poi, Craig C Hofmeister, Jeffrey S Johnston, Ryan B Edwards, Buffy S Jansak

Clin Pharmacokinet· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol.
Lapo Alinari, Courtney J Prince, Ryan B Edwards, William H Towns, Rajeswaran Mani

Clin Cancer Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells.
Sneha V Gupta, Ellen J Sass, Melanie E Davis, Ryan B Edwards, Gerard Lozanski

AAPS J· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo.
David M Lucas, Lapo Alinari, Derek A West, Melanie E Davis, Ryan B Edwards

PLoS One· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.
David M Lucas, Ryan B Edwards, Gerard Lozanski, Derek A West, Jungook D Shin

Blood· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia.
Amy J Johnson, David M Lucas, Natarajan Muthusamy, Lisa L Smith, Ryan B Edwards

Blood· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis